Robert Bowdring
2019 - INVO Bioscience
In 2019, Robert Bowdring earned a total compensation of $365.9K as Former Chief Financial Officer at INVO Bioscience, a 205% increase compared to previous year.
Compensation breakdown
| Option Awards | $317,737 |
|---|---|
| Salary | $48,125 |
| Total | $365,862 |
Bowdring received $317.7K in option awards, accounting for 87% of the total pay in 2019.
Bowdring also received $48.1K in salary.
Rankings
In 2019, Robert Bowdring's compensation ranked 12,543rd out of 13,971 executives tracked by ExecPay. In other words, Bowdring earned more than 10.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,543 out of 13,971 | 10th |
Division Manufacturing | 5,070 out of 5,701 | 11th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 716 out of 832 | 14th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 462 out of 535 | 14th |
Industry Surgical and Medical Instruments and Apparatus | 305 out of 350 | 13th |
Source: SEC filing on November 20, 2020.
Bowdring's colleagues
We found five more compensation records of executives who worked with Robert Bowdring at INVO Bioscience in 2019.
2019
Steven Shum
INVO Bioscience
Chief Executive Officer
2019
Kathleen Karloff
INVO Bioscience
Chief Executive Officer
2019
Michael Campbell
INVO Bioscience
Chief Operating Officer
2019
Lori Marzilli-Kahler
INVO Bioscience
Former VP, Global Operations
2019
Debra Hoopes
INVO Bioscience